Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion-Reference-Cited by-同舟云学术

Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion

Published:2024-02 Issue: Volume:254 Page:155145
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Angerilli Valentina,Ghelardi Filippo,Nappo Floriana,Grillo Federica,Parente Paola,Lonardi Sara,Luchini Claudio,Pietrantonio Filippo,Ugolini Clara,Vanoli Alessandro,Fassan Matteo

Funder

Astellas Pharma Europe Ltd

Astellas Pharma US

Publisher

Elsevier BV

Reference116 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Changing trends in stomach cancer throughout the world;Balakrishnan;Curr. Gastroenterol. Rep.,2017

3. Risk of gastric cancer development after eradication of Helicobacter pylori;Cheung;World J. Gastrointest. Oncol.,2018

4. The esophagogastric junctional adenocarcinoma an increasing disease;Pastina;J. Thorac. Dis.,2017

5. Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review;Schirren;Ther. Adv. Med. Oncol.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adenocarcinoma - real-world evidence;Translational Oncology;2024-09

2. The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer;Expert Opinion on Drug Discovery;2024-06-26

3. Construction of a Human Immune Library from Gallbladder Cancer Patients for the Single-Chain Fragment Variable (scFv) Antibody Selection against Claudin 18.2 via Phage Display;Antibodies;2024-03-12